Mehilaeinen Oy

The clinical research at Mehilaeinen Oy includes studies in mental disorders focused on major depressive disorder and generalized anxiety disorder. These trials are designed to assess whether new treatments can better relieve symptoms and help people who have not responded well to standard care.

• Testing new options for major depressive disorder, including depression with anhedonia
• Evaluating treatments for generalized anxiety disorder when current therapy is not enough
• Studying both symptom improvement and longer-term treatment tolerability

This area reflects a strong interest in improving everyday mental health care through more effective and better-tolerated therapies.

Research in nervous system diseases includes work on relapsing multiple sclerosis and normal tension glaucoma. The studies aim to understand whether new or repurposed treatments can help preserve function, slow disease impact, and improve patient outcomes.

• Examining long-term safety and effectiveness in relapsing multiple sclerosis
• Investigating treatment approaches for normal tension glaucoma
• Using imaging and visual testing to explore disease response in eye-related nerve conditions

These trials connect neurological and eye health research, showing a broad interest in conditions that affect the nervous system and vision.

The site is also involved in eye disease research, with studies focused on normal tension glaucoma. The goal is to evaluate whether new treatment strategies can improve optic nerve blood flow and support better visual preservation.

• Assessing treatment effects in normal tension glaucoma
• Exploring whether added therapy may improve optic nerve circulation
• Monitoring anatomical and functional eye responses to treatment

This research may help expand options for patients with glaucoma who need better ways to protect vision.

Clinical trials in immune system diseases include moderate to severe atopic dermatitis. The research is aimed at finding therapies that can reduce inflammation, improve skin symptoms, and support people who need systemic treatment.

• Evaluating new treatment approaches for atopic dermatitis
• Studying symptom control in adolescents and adults with more severe disease
• Assessing overall treatment safety and patient tolerability

These studies reflect a practical focus on improving quality of life for patients living with chronic inflammatory skin disease.

In cancer research, the site is studying metastatic castration-resistant prostate cancer, including cases with PSMA expression. The trials are exploring new anticancer therapies to better target advanced disease and evaluate how they work in the body.

• Investigating treatments for advanced metastatic castration-resistant prostate cancer
• Assessing anticancer activity in PSMA-positive prostate cancer
• Focusing on treatment response, safety, and overall tolerability

This oncology research highlights efforts to expand options for men with difficult-to-treat advanced prostate cancer.

Research in female urogenital diseases includes studies on vasomotor symptoms linked to adjuvant endocrine therapy in women with, or at risk for, hormone-receptor positive breast cancer. The purpose is to improve symptom control during cancer treatment.

• Testing treatments for hot flashes caused by endocrine therapy
• Supporting women receiving care for hormone-receptor positive breast cancer
• Evaluating whether new options can ease treatment-related discomfort

These trials address an important quality-of-life issue that can affect ongoing cancer care.